Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

D-Cycloserine (CAS 68-41-7)

0.0(0)
Write a reviewAsk a question

See product citations (4)

Alternate Names:
(R)-4-Amino-3-isoxazolidone
Application:
D-Cycloserine is antibiotic and a partial agonist of NMDA receptors at the glycine modulatory site
CAS Number:
68-41-7
Purity:
≥98%
Molecular Weight:
102.09
Molecular Formula:
C3H6N2O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

D-Cycloserine is a partial agonist of NMDA receptors at the glycine site. D-Cycloserine has experimentally been shown to facilitate activation of the receptor and thereby improve memory and cognition. An amino acid analog, D-Cycloserine inhibits bacterial cell wall biosynthesis.


D-Cycloserine (CAS 68-41-7) References

  1. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.  |  Tsai, GE., et al. 1999. Am J Psychiatry. 156: 467-9. PMID: 10080566
  2. Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze.  |  Pussinen, R. and Sirviö, J. 1999. J Psychopharmacol. 13: 171-9. PMID: 10475724
  3. RS 67333 and D-cycloserine accelerate learning acquisition in the rat.  |  Lelong, V., et al. 2001. Neuropharmacology. 41: 517-22. PMID: 11543772
  4. THE ENZYMATIC SYNTHESIS OF D-ALANYL-D-ALANINE. 3. ON THE INHIBITION OF D-ALANYL-D-ALANINE SYNTHETASE BY THE ANTIBIOTIC D-CYCLOSERINE.  |  NEUHAUS, FC. and LYNCH, JL. 1964. Biochemistry. 3: 471-80. PMID: 14188160
  5. A pilot study of D-cycloserine in subjects with autistic disorder.  |  Posey, DJ., et al. 2004. Am J Psychiatry. 161: 2115-7. PMID: 15514414
  6. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.  |  Ressler, KJ., et al. 2004. Arch Gen Psychiatry. 61: 1136-44. PMID: 15520361
  7. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.  |  Norberg, MM., et al. 2008. Biol Psychiatry. 63: 1118-26. PMID: 18313643
  8. Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors.  |  Dravid, SM., et al. 2010. J Neurosci. 30: 2741-54. PMID: 20164358
  9. Impaired extinction retention in adolescent rats: effects of D-cycloserine.  |  McCallum, J., et al. 2010. Neuropsychopharmacology. 35: 2134-42. PMID: 20592716
  10. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.  |  Heresco-Levy, U., et al. 2013. Int J Neuropsychopharmacol. 16: 501-6. PMID: 23174090
  11. D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.  |  Hood, WF., et al. 1989. Neurosci Lett. 98: 91-5. PMID: 2540460
  12. Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W.  |  Lambert, MP. and Neuhaus, FC. 1972. J Bacteriol. 110: 978-87. PMID: 4555420
  13. Mechanism of D-cycloserine action: transport mutants for D-alanine, D-cycloserine, and glycine.  |  Wargel, RJ., et al. 1971. J Bacteriol. 105: 1028-35. PMID: 4926674
  14. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam.  |  Baran, H., et al. 1994. Brain Res. 652: 195-200. PMID: 7953730
  15. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.  |  Cáceres, NE., et al. 1997. J Bacteriol. 179: 5046-55. PMID: 9260945

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

D-Cycloserine, 200 mg

sc-221470
200 mg
$28.00

D-Cycloserine, 1 g

sc-221470A
1 g
$77.00

D-Cycloserine, 5 g

sc-221470B
5 g
$142.00

D-Cycloserine, 25 g

sc-221470C
25 g
$530.00